Literature DB >> 8239577

Microbial conversion of avermectins by Saccharopolyspora erythraea: glycosylation at C-4' and C-4''.

M Schulman1, P Doherty, B Arison.   

Abstract

Avermectins and ivermectins are glycosylated at C-4'' and C-4' by both growing and resting cells of Saccharopolyspora erythraea. The reaction is catalyzed by a glycosyltransferase which is constitutive. The enzyme uses UDP-glucose as the glycosyl donor and avermectin or ivermectin mono- and disaccharides as acceptors. Avermectin and ivermectin aglycones and erythromycin A are not substrates for the enzyme.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8239577      PMCID: PMC188062          DOI: 10.1128/AAC.37.9.1737

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  S-adenosylmethionine:erythromycin C O-methyltransferase.

Authors:  J W Corcoran
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Structure of a phosphorylated derivative of oleandomycin, obtained by reaction of oleandomycin with an extract of an erythromycin-resistant strain of Escherichia coli.

Authors:  K O'Hara; T Kanda; M Kono
Journal:  J Antibiot (Tokyo)       Date:  1988-06       Impact factor: 2.649

3.  Avermectins, new family of potent anthelmintic agents: isolation and chromatographic properties.

Authors:  T W Miller; L Chaiet; D J Cole; L J Cole; J E Flor; R T Goegelman; V P Gullo; H Joshua; A J Kempf; W R Krellwitz; R L Monaghan; R E Ormond; K E Wilson; G Albers-Schönberg; I Putter
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

4.  Insecticidal activity of the anti-parasitic avermectins.

Authors:  D A Ostlind; S Cifelli; R Lang
Journal:  Vet Rec       Date:  1979-08-25       Impact factor: 2.695

5.  Microbial conversion of avermectins by Saccharopolyspora erythrea: hydroxylation at C28.

Authors:  M Schulman; P Doherty; D Zink; B Arison
Journal:  J Antibiot (Tokyo)       Date:  1993-06       Impact factor: 2.649

Review 6.  Translational attenuation: the regulation of bacterial resistance to the macrolide-lincosamide-streptogramin B antibiotics.

Authors:  D Dubnau
Journal:  CRC Crit Rev Biochem       Date:  1984

7.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics.

Authors:  R Skinner; E Cundliffe; F J Schmidt
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

8.  Avermectins, new family of potent anthelmintic agents: efficacy of the B1a component.

Authors:  J R Egerton; D A Ostlind; L S Blair; C H Eary; D Suhayda; S Cifelli; R F Riek; W C Campbell
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

9.  Avermectins, new family of potent anthelmintic agents: producing organism and fermentation.

Authors:  R W Burg; B M Miller; E E Baker; J Birnbaum; S A Currie; R Hartman; Y L Kong; R L Monaghan; G Olson; I Putter; J B Tunac; H Wallick; E O Stapley; R Oiwa; S Omura
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

10.  Demethylavermectins. Biosynthesis, isolation and characterization.

Authors:  M D Schulman; D Valentino; O D Hensens; D Zink; M Nallin; L Kaplan; D A Ostlind
Journal:  J Antibiot (Tokyo)       Date:  1985-11       Impact factor: 2.649

View more
  3 in total

1.  New tenvermectin analogs obtained by microbial conversion with Saccharopolyspora erythraea.

Authors:  Xu Wan; Shao-Yong Zhang; Hui Zhang; Jun Zhai; Jun Huang; An-Liang Chen; Ji-Dong Wang
Journal:  J Antibiot (Tokyo)       Date:  2016-07-20       Impact factor: 2.649

2.  Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species.

Authors:  K Yazawa; Y Mikami; T Sakamoto; Y Ueno; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

3.  Midecamycin Is Inactivated by Several Different Sugar Moieties at Its Inactivation Site.

Authors:  Ru Lin; Li-Li Hong; Zhong-Ke Jiang; Ke-Meng Li; Wei-Qing He; Jian-Qiang Kong
Journal:  Int J Mol Sci       Date:  2021-11-23       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.